Publications by authors named "Salsabil Ayman"

Article Synopsis
  • * The effectiveness of these compounds was tested against various human cancer cell lines, with some showing strong antiproliferative properties and low toxicity to normal cells, indicating a promising therapeutic potential.
  • * Among the tested derivatives, compound 10a emerged as the most potent EGFR inhibitor, demonstrating significant binding and inhibition compared to a reference drug, Erlotinib, emphasizing its potential as an anticancer agent.
View Article and Find Full Text PDF